SyntekaBio, Inc. (KOSDAQ:226330)
South Korea
· Delayed Price · Currency is KRW 7,210.00
-310.00 (-4.12%)
At close: Mar 28, 2025, 3:30 PM KST
SyntekaBio Revenue
In the year 2024, SyntekaBio had annual revenue of 120.89M KRW, down -2.04%. SyntekaBio had revenue of 113.20M in the quarter ending December 31, 2024, a decrease of -1.26%.
Revenue
120.89M
Revenue Growth
-2.04%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
62
Market Cap
104.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 120.89M | -2.52M | -2.04% |
| Dec 31, 2023 | 123.41M | -120.59M | -49.42% |
| Dec 31, 2022 | 243.99M | -72.67M | -22.95% |
| Dec 31, 2021 | 316.66M | -293.02M | -48.06% |
| Dec 31, 2020 | 609.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Kia Corporation | 107.45T |
| Celltrion | 3,557.30B |
| KB Financial Group | 15.01T |